Stories

Hospital Stocks Face Pressure As Government Caps Oncology Drug Margins

Why Insurance Matters
Medical insurance protects you from unpredictable and often extremely high medical expenses. With adequate coverage, hospitalisation costs no longer have to be a financial burden — you can get treated at the best hospitals without worrying about the bill. Health policies also come with an added advantage: they're eligible for tax benefits under Section 80D of the IT Act. Understanding these benefits is the first step before comparing the many options available in the market.

CNBC TV18•19-10-2026, 07:14

•Shares of major hospital chains like Apollo Hospitals, Max Healthcare, Fortis Healthcare, and Healthcare Global are expected to face market pressure following an NPPA order.
•The government has capped trade margins on 138 non-scheduled oncology drugs at 30 percent of the Maximum Retail Price, effective from November 9, 2026.
•Analysts warn that hospital pharmacy margins and Average Revenue Per Operating Bed metrics will take a negative hit, forcing hospitals to absorb the margin squeeze.
•Brokerage firm Nuvama estimates a 4 percent financial impact on Max Healthcare and a 1 to 2 percent impact on other hospital operators.
•Healthcare Global Chairman BS Ajaikumar noted that pharma companies often avoid manufacturing certain cancer drugs due to low profit margins.

Read Full Article on CNBC TV18 in English

Key Questions Answered

Shares of hospital and healthcare providers are facing downward pressure after the government capped trade margins on 138 non-scheduled oncology drugs at 30% of the Maximum Retail Price via an NPPA order.

The revised price norms and trade margin caps set by the NPPA will officially become effective starting from November 9, 2026.

Analysts predict near-term headwinds to the Average Revenue Per Operating Bed and profit margins for oncology-focused hospitals, with brokerage firm Nuvama estimating a 4% impact on Max Healthcare and a 1% to 2% impact for others.